Ho M - Search Results

1

R-spondins engage heparan sulfate proteoglycans to potentiate WNT signaling.

Dubey R, van Kerkhof P, Jordens I, Malinauskas T, Pusapati GV, McKenna JK, Li D, Carette JE, Ho M, Siebold C, Maurice M, Lebensohn AM, Rohatgi R. Dubey R, et al. Among authors: ho m. Elife. 2020 May 20;9:e54469. doi: 10.7554/eLife.54469. Elife. 2020. PMID: 32432544 Free PMC article.

2

Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy.

Gao W, Kim H, Feng M, Phung Y, Xavier CP, Rubin JS, Ho M. Gao W, et al. Among authors: ho m. Hepatology. 2014 Aug;60(2):576-87. doi: 10.1002/hep.26996. Epub 2014 Jun 18. Hepatology. 2014. PMID: 24492943 Free PMC article.

3

A Frizzled-Like Cysteine-Rich Domain in Glypican-3 Mediates Wnt Binding and Regulates Hepatocellular Carcinoma Tumor Growth in Mice.

Li N, Wei L, Liu X, Bai H, Ye Y, Li D, Li N, Baxa U, Wang Q, Lv L, Chen Y, Feng M, Lee B, Gao W, Ho M. Li N, et al. Among authors: ho m. Hepatology. 2019 Oct;70(4):1231-1245. doi: 10.1002/hep.30646. Epub 2019 May 24. Hepatology. 2019. PMID: 30963603 Free PMC article.

4

Advances in immunotherapeutic targets for childhood cancers: A focus on glypican-2 and B7-H3.

Li N, Spetz MR, Li D, Ho M. Li N, et al. Among authors: ho m. Pharmacol Ther. 2021 Jul;223:107892. doi: 10.1016/j.pharmthera.2021.107892. Epub 2021 May 14. Pharmacol Ther. 2021. PMID: 33992682 Free PMC article. Review.

5

A novel PD-L1-targeted shark V_NAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer.

Li D, English H, Hong J, Liang T, Merlino G, Day CP, Ho M. Li D, et al. Among authors: ho m. Mol Ther Oncolytics. 2022 Feb 20;24:849-863. doi: 10.1016/j.omto.2022.02.015. eCollection 2022 Mar 17. Mol Ther Oncolytics. 2022. PMID: 35317524 Free PMC article.

6

Immunotherapy for hepatobiliary cancers: Emerging targets and translational advances.

Li D, Lin S, Hong J, Ho M. Li D, et al. Among authors: ho m. Adv Cancer Res. 2022;156:415-449. doi: 10.1016/bs.acr.2022.01.013. Epub 2022 Feb 18. Adv Cancer Res. 2022. PMID: 35961708 Review.

7

Human VH-based chimeric antigen receptor T cells targeting glypican 3 eliminate tumors in preclinical models of HCC.

Kolluri A, Li D, Li N, Duan Z, Roberts LR, Ho M. Kolluri A, et al. Among authors: ho m. Hepatol Commun. 2023 Jan 18;7(2):e0022. doi: 10.1097/HC9.0000000000000022. eCollection 2023 Feb 1. Hepatol Commun. 2023. PMID: 36691969 Free PMC article.

8

Identification of nurse shark V_NAR single-domain antibodies targeting the spike S2 subunit of SARS-CoV-2.

Buffington J, Duan Z, Kwon HJ, Hong J, Li D, Feng M, Xie H, Ho M. Buffington J, et al. Among authors: ho m. FASEB J. 2023 Jun;37(6):e22973. doi: 10.1096/fj.202202099RR. FASEB J. 2023. PMID: 37191949 Free PMC article.

9

CAR-T cells based on a TCR mimic nanobody targeting HPV16 E6 exhibit antitumor activity against cervical cancer.

Duan Z, Li D, Li N, Lin S, Ren H, Hong J, Hinrichs CS, Ho M. Duan Z, et al. Among authors: ho m. Mol Ther Oncol. 2024 Oct 9;32(4):200892. doi: 10.1016/j.omton.2024.200892. eCollection 2024 Dec 19. Mol Ther Oncol. 2024. PMID: 39524212 Free PMC article.

10

Human Monoclonal Antibody Targeting the Heparan Sulfate Chains of Glypican-3 Inhibits HGF-Mediated Migration and Motility of Hepatocellular Carcinoma Cells.

Gao W, Kim H, Ho M. Gao W, et al. Among authors: ho m. PLoS One. 2015 Sep 2;10(9):e0137664. doi: 10.1371/journal.pone.0137664. eCollection 2015. PLoS One. 2015. PMID: 26332121 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,224 results

Search Page

Filters